Robert A. Bradway - Apr 30, 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Chairman, CEO and President, Director
Signature: /s/ Robert A. Bradway
Stock symbol: AMGN
Transactions as of: Apr 30, 2023
Transactions value $: -$529,346
Form type: 4
Date filed: 5/2/2023, 08:15 PM
Previous filing: Apr 5, 2023
Next filing: May 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability	-$529K	-2.21K	-0.35%	$239.74	633K	Apr 30, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,369 RSUs which will vest on 5/3/2023; 8,164 RSUs which vest in installments of 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 8.898 RSUs which vest in installments of 4,382 on 4/30/2024 and 4,516 on 4/30/2025; and 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2	These shares include 2,508 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,369 RSUs which will vest on 5/3/2023; 8,164 RSUs which vest in installments of 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 8.898 RSUs which vest in installments of 4,382 on 4/30/2024 and 4,516 on 4/30/2025; and 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

These shares include 2,508 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.